Hideo Yagi

2.7k citations

58 papers · 1.7k indexed · h-index 21

Co-authors: Masanori Matsumoto Yoshihiro Fujimura Hiromichi Ishizashi Toshiyuki Miyata Koichi Kokame Kenji Soejima Hideo Wada Mutsuko Konno
Topics: Complement system in diseases (38 papers)Platelet Disorders and Treatments (29 papers)Renal Diseases and Glomerulopathies (16 papers)
Cited by: Hematology Nephrology Immunology
Journals: Proceedings of the National Academy of Sciences Blood PLoS ONE
Partner nations: Japan United States Nigeria

In The Last Decade

Hideo Yagi

54 papers receiving 1.7k citations

Peers

Countries citing papers authored by Hideo Yagi

Since Specialization

Citations

This map shows the geographic impact of Hideo Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideo Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideo Yagi more than expected).

Fields of papers citing papers by Hideo Yagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideo Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideo Yagi. The network helps show where Hideo Yagi may publish in the future.

Co-authorship network of co-authors of Hideo Yagi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideo Yagi. A scholar is included among the top collaborators of Hideo Yagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideo Yagi. Hideo Yagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP 2024 ·Blood Advances ·(unknown),Kazuya Sakai,Masayuki Kubo,(unknown),(unknown),(unknown),(unknown),(unknown),Yoshiyuki Ogawa,Hideo Yagi,Masanori Matsumoto	6
2	Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023 2023 ·International Journal of Hematology ·Masanori Matsumoto,Yoshitaka Miyakawa,Koichi Kokame,Yasunori Ueda,Hideo Wada,Satoshi Higasa,Hideo Yagi,Yoshiyuki Ogawa,Kazuya Sakai,Toshiyuki Miyata,Eriko Morishita,Yoshihiro Fujimura	15
3	Two cases of sporadic adult-onset neuronal intranuclear inclusion disease preceded by urinary disturbance for many years 2018 ·Journal of the Neurological Sciences ·Masataka Nakamura,(unknown),(unknown),Hideo Yagi,(unknown),(unknown),Ichiro Akiguchi,Hirofumi Kusaka,Takayuki Kondo	25
4	Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation 2017 ·Annals of Oncology ·(unknown),Naoki Takezako,Jianbiao Zheng,Martin Moorhead,Victoria Carlton,Katherine A. Kong,(unknown),Shigeki Ito,(unknown),Kenji Yokoyama,Kosei Matsue,Toyotaka Sato,Toshiro Kurokawa,Hideo Yagi,(unknown),Kohei Ohata,Morio Matsumoto,Takashi Yoshida,Malek Faham,Shinji Nakao	33
5	Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity 2017 ·Thrombosis Research ·Hideo Yagi,Naoko Yamaguchi,(unknown),Mitsuhiko Sugimoto,(unknown),Yoshihiro Fujimura,Masanori Matsumoto	7
6	Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity 2012 ·European Journal of Pharmacology ·Hideo Yagi,Naoko Yamaguchi,(unknown),Masaki Hayakawa,Masanori Matsumoto,Mitsuhiko Sugimoto,Hideo Wada,Kazuo Tsubaki,Yoshihiro Fujimura	4
7	Only Therapeutic ICOS:ICOSL Blockade Alleviates Acute Graft versus Host Disease 2009 ·Klinische Pädiatrie ·(unknown),Martin S. Staege,Christoph Hoeschen,Hideo Yagi,Stefan Burdach,Günther Richter	5
8	RNA aptamers specifically interact with the Fc region of mouse immunoglobulin G 2008 ·Nucleic Acids Symposium Series ·Nobuya Sakai,Hiromi Masuda,(unknown),Hideo Yagi,(unknown),Katsunori Horii,(unknown),Iwao Waga	12
9	Brain Nerve Symptoms due to Thrombotic Microangiopathy 2007 ·Nihon Naika Gakkai Zasshi ·Hideo Yagi,Masanori Matsumoto,Yoshihiro Fujimura	1
10	Plasma Levels of ADAMTS13 Antigen Determined with an Enzyme Immunoassay Using a Neutralizing Monoclonal Antibody Parallel ADAMTS13 Activity LevEls 2007 ·International Journal of Hematology ·Hideo Yagi,Shin Ito,Seiji Kato,(unknown),Masanori Matsumoto,Yoshihiro Fujimura	16
11	Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi‐center prospective study 2006 ·Journal of Thrombosis and Haemostasis ·Masataka Kuwana,Y. Kurata,K Fujimura,K Fujisawa,Hideo Wada,Toshiro Nagasawa,Shosaku� Nomura,Tetsuhito Kojima,Hideo Yagi,Y. Ikeda	44
12	Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndrome 2006 ·Thrombosis Research ·Hiromichi Ishizashi,Hideo Yagi,Masanori Matsumoto,Kenji Soejima,Tomohiro Nakagaki,Yoshihiro Fujimura	13
13	Platelets Treated with Ticlopidine Are Less Reactive to Unusually Large von Willebrand Factor Multimers than Are Those Treated with Aspirin under High Shear Stress 2005 ·Pathophysiology of Haemostasis and Thrombosis ·Masanori Matsumoto,(unknown),Hiromichi Ishizashi,Hideo Yagi,Junichi Iida,(unknown),Yoshihiro Fujimura	38
14	von Willebrand Factor—Cleaving Protease and Upshaw-Schulman Syndrome 2002 ·International Journal of Hematology ·Yoshihiro Fujimura,Masanori Matsumoto,Hideo Yagi,Akira Yoshioka,Taei Matsui,Koiti Titani	70
15	Low-Dosage Intravenous Immunoglobulin in the Management of a Patient with Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance 2002 ·Pathophysiology of Haemostasis and Thrombosis ·T Hayashi,Hideo Yagi,Hidenori Suzuki,(unknown),(unknown),Yoshihiko Sakurai,(unknown),Mika Matsumoto,Yasuhiro Yamamoto,Yoshihiro Fujimura	11
16	Deterioration in learning and memory of fear conditioning in response to context in aged SAMP8 mice 1 1Abbreviations: SAM, senescence-accelerated mouse; SAMP, senescence-accelerated mouse prone; SAMR, senescence-accelerated mouse resistant; GABA, gamma-aminobutyric acid; MGRF, magnocelluar reticular formation; RSA, hippocampal rhythmic slow activity; CS, conditioned stimulus. 2001 ·Neurobiology of Aging ·Akira Ohta,Ichiro Akiguchi,(unknown),Katsunori Ohnishi,Hideo Yagi,Keiichi Higuchi,Masanori Hosokawa	29
17	Plasma of patients with Upshaw–Schulman syndrome, a congenital deficiency of von Willebrand factor‐cleaving protease activity, enhances the aggregation of normal platelets under high shear stress 2001 ·British Journal of Haematology ·Hideo Yagi,Mutsuko Konno,S Kinoshita,Masanori Matsumoto,Hiromichi Ishizashi,Taei Matsui,Koiti Titani,Yoshihiro Fujimura	24
18	Upshaw-Schulman Syndrome Revisited: A Concept of Congenital Thrombotic Thrombocytopenic Purpura 2001 ·International Journal of Hematology ·S Kinoshita,Akira Yoshioka,(unknown),Hiromichi Ishizashi,Mutsuko Konno,(unknown),Taei Matsui,Koiti Titani,Hideo Yagi,Masanori Matsumoto,Yoshihiro Fujimura	90
19	The cDNA cloning of human placental ecto‐ATP diphosphohydrolases I and II¹ 1999 ·FEBS Letters ·Masanori Matsumoto,Yoshihiko Sakurai,Tetsuro Kokubo,Hideo Yagi,Kaori Makita,Taei Matsui,Koiti Titani,(unknown),Nobuhiro Narita	19
20	Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1‐loop fragments 1999 ·British Journal of Haematology ·Shuji Miura,Yoshihiko Sakurai,(unknown),Akira Yoshioka,Masanori Matsumoto,Hideo Yagi,Tetsuro Kokubo,Yasuo Ikeda,Taei Matsui,Koiti Titani,Yoshihiro Fujimura	8

About Hideo Yagi

Hideo Yagi is a scholar working on Hematology, Nephrology and Immunology, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Complement system in diseases (38 papers), Platelet Disorders and Treatments (29 papers) and Renal Diseases and Glomerulopathies (16 papers). The work is most often cited by research in Hematology (949 citations), Nephrology (584 citations) and Immunology (1.3k citations). Hideo Yagi has collaborated with scholars based in Japan, United States and Nigeria. Frequent co-authors include Masanori Matsumoto, Yoshihiro Fujimura, Hiromichi Ishizashi, Toshiyuki Miyata, Koichi Kokame, Kenji Soejima, Hideo Wada, Mutsuko Konno, Taei Matsui and Hiroshi Tamai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact